private:atomwise
|
3357332
|
Apr 21st, 2024 12:00AM
|
Atomwise
|
19K
|
63.00
|
Open
|
|
Apr 21st, 2024 05:12AM
|
Apr 21st, 2024 05:12AM
|
Atomwise is a preclinical pharma company revolutionizing how drugs are discovered with AI. Atomwise has strengthened its drug discovery and development expertise by expanding its Board of Directors and creating a Scientific Advisory Board (SAB). These appointments signal a critical milestone for Atomwise as the company focuses on its own internal pipeline.
We invented the use of deep learning for structure-based drug discovery, today developing a pipeline of small-molecule drug candidates advancing into preclinical studies. Our AtomNet® technology has been used to unlock more undruggable targets than any other AI drug discovery platform. We are tackling over 600 unique disease targets with more than 250 partners around the world, including leading pharmaceutical, agrochemical, and emerging biotechnology companies. Atomwise has raised over $174 million from leading venture capital firms to advance our mission to make better medicines, faster.
We’re at a critical time in history where our need for new kinds of medicines is greater than any time in human memory. Fortunately, we can leverage advancing technology and scientific breakthroughs to accelerate discovery. New data, new algorithms, new compute platforms lift all of us, enable our work on the hardest of problems, empower us to invent and create, and ultimately save one billion lives. Join us: www.atomwise.com/careers
|
Open
|
Machine Learning, Artificial Intelligence, Drug Discovery, and Computer Aided Drug Design
|
Open
|
717 Market St.
|
San Francisco
|
California
|
US
|
94103
|
|
Atomwise
|
Health Care
|
Health Care Equipment & Services
|
private:atomwise
|
3357332
|
Apr 20th, 2024 12:00AM
|
Atomwise
|
19K
|
63.00
|
Open
|
|
Apr 20th, 2024 04:12AM
|
Apr 20th, 2024 07:30PM
|
Atomwise is a preclinical pharma company revolutionizing how drugs are discovered with AI. Atomwise has strengthened its drug discovery and development expertise by expanding its Board of Directors and creating a Scientific Advisory Board (SAB). These appointments signal a critical milestone for Atomwise as the company focuses on its own internal pipeline.
We invented the use of deep learning for structure-based drug discovery, today developing a pipeline of small-molecule drug candidates advancing into preclinical studies. Our AtomNet® technology has been used to unlock more undruggable targets than any other AI drug discovery platform. We are tackling over 600 unique disease targets with more than 250 partners around the world, including leading pharmaceutical, agrochemical, and emerging biotechnology companies. Atomwise has raised over $174 million from leading venture capital firms to advance our mission to make better medicines, faster.
We’re at a critical time in history where our need for new kinds of medicines is greater than any time in human memory. Fortunately, we can leverage advancing technology and scientific breakthroughs to accelerate discovery. New data, new algorithms, new compute platforms lift all of us, enable our work on the hardest of problems, empower us to invent and create, and ultimately save one billion lives. Join us: www.atomwise.com/careers
|
Open
|
Machine Learning, Artificial Intelligence, Drug Discovery, and Computer Aided Drug Design
|
Open
|
717 Market St.
|
San Francisco
|
California
|
US
|
94103
|
|
Atomwise
|
Health Care
|
Health Care Equipment & Services
|
private:atomwise
|
3357332
|
Apr 19th, 2024 12:00AM
|
Atomwise
|
19K
|
63.00
|
Open
|
|
Apr 19th, 2024 06:34AM
|
Apr 19th, 2024 06:34AM
|
Atomwise is a preclinical pharma company revolutionizing how drugs are discovered with AI. Atomwise has strengthened its drug discovery and development expertise by expanding its Board of Directors and creating a Scientific Advisory Board (SAB). These appointments signal a critical milestone for Atomwise as the company focuses on its own internal pipeline.
We invented the use of deep learning for structure-based drug discovery, today developing a pipeline of small-molecule drug candidates advancing into preclinical studies. Our AtomNet® technology has been used to unlock more undruggable targets than any other AI drug discovery platform. We are tackling over 600 unique disease targets with more than 250 partners around the world, including leading pharmaceutical, agrochemical, and emerging biotechnology companies. Atomwise has raised over $174 million from leading venture capital firms to advance our mission to make better medicines, faster.
We’re at a critical time in history where our need for new kinds of medicines is greater than any time in human memory. Fortunately, we can leverage advancing technology and scientific breakthroughs to accelerate discovery. New data, new algorithms, new compute platforms lift all of us, enable our work on the hardest of problems, empower us to invent and create, and ultimately save one billion lives. Join us: www.atomwise.com/careers
|
Open
|
Machine Learning, Artificial Intelligence, Drug Discovery, and Computer Aided Drug Design
|
Open
|
717 Market St.
|
San Francisco
|
California
|
US
|
94103
|
|
Atomwise
|
Health Care
|
Health Care Equipment & Services
|
private:atomwise
|
3357332
|
Apr 18th, 2024 12:00AM
|
Atomwise
|
19K
|
63.00
|
Open
|
|
Apr 18th, 2024 05:15AM
|
Apr 18th, 2024 08:49PM
|
Atomwise is a preclinical pharma company revolutionizing how drugs are discovered with AI. Atomwise has strengthened its drug discovery and development expertise by expanding its Board of Directors and creating a Scientific Advisory Board (SAB). These appointments signal a critical milestone for Atomwise as the company focuses on its own internal pipeline.
We invented the use of deep learning for structure-based drug discovery, today developing a pipeline of small-molecule drug candidates advancing into preclinical studies. Our AtomNet® technology has been used to unlock more undruggable targets than any other AI drug discovery platform. We are tackling over 600 unique disease targets with more than 250 partners around the world, including leading pharmaceutical, agrochemical, and emerging biotechnology companies. Atomwise has raised over $174 million from leading venture capital firms to advance our mission to make better medicines, faster.
We’re at a critical time in history where our need for new kinds of medicines is greater than any time in human memory. Fortunately, we can leverage advancing technology and scientific breakthroughs to accelerate discovery. New data, new algorithms, new compute platforms lift all of us, enable our work on the hardest of problems, empower us to invent and create, and ultimately save one billion lives. Join us: www.atomwise.com/careers
|
Open
|
Machine Learning, Artificial Intelligence, Drug Discovery, and Computer Aided Drug Design
|
Open
|
717 Market St.
|
San Francisco
|
California
|
US
|
94103
|
|
Atomwise
|
Health Care
|
Health Care Equipment & Services
|
private:atomwise
|
3357332
|
Apr 17th, 2024 12:00AM
|
Atomwise
|
19K
|
63.00
|
Open
|
|
Apr 17th, 2024 06:34AM
|
Apr 17th, 2024 05:17PM
|
Atomwise is a preclinical pharma company revolutionizing how drugs are discovered with AI. Atomwise has strengthened its drug discovery and development expertise by expanding its Board of Directors and creating a Scientific Advisory Board (SAB). These appointments signal a critical milestone for Atomwise as the company focuses on its own internal pipeline.
We invented the use of deep learning for structure-based drug discovery, today developing a pipeline of small-molecule drug candidates advancing into preclinical studies. Our AtomNet® technology has been used to unlock more undruggable targets than any other AI drug discovery platform. We are tackling over 600 unique disease targets with more than 250 partners around the world, including leading pharmaceutical, agrochemical, and emerging biotechnology companies. Atomwise has raised over $174 million from leading venture capital firms to advance our mission to make better medicines, faster.
We’re at a critical time in history where our need for new kinds of medicines is greater than any time in human memory. Fortunately, we can leverage advancing technology and scientific breakthroughs to accelerate discovery. New data, new algorithms, new compute platforms lift all of us, enable our work on the hardest of problems, empower us to invent and create, and ultimately save one billion lives. Join us: www.atomwise.com/careers
|
Open
|
Machine Learning, Artificial Intelligence, Drug Discovery, and Computer Aided Drug Design
|
Open
|
717 Market St.
|
San Francisco
|
California
|
US
|
94103
|
|
Atomwise
|
Health Care
|
Health Care Equipment & Services
|
private:atomwise
|
3357332
|
Apr 16th, 2024 12:00AM
|
Atomwise
|
19K
|
63.00
|
Open
|
|
Apr 16th, 2024 03:58AM
|
Apr 16th, 2024 01:35PM
|
Atomwise is a preclinical pharma company revolutionizing how drugs are discovered with AI. Atomwise has strengthened its drug discovery and development expertise by expanding its Board of Directors and creating a Scientific Advisory Board (SAB). These appointments signal a critical milestone for Atomwise as the company focuses on its own internal pipeline.
We invented the use of deep learning for structure-based drug discovery, today developing a pipeline of small-molecule drug candidates advancing into preclinical studies. Our AtomNet® technology has been used to unlock more undruggable targets than any other AI drug discovery platform. We are tackling over 600 unique disease targets with more than 250 partners around the world, including leading pharmaceutical, agrochemical, and emerging biotechnology companies. Atomwise has raised over $174 million from leading venture capital firms to advance our mission to make better medicines, faster.
We’re at a critical time in history where our need for new kinds of medicines is greater than any time in human memory. Fortunately, we can leverage advancing technology and scientific breakthroughs to accelerate discovery. New data, new algorithms, new compute platforms lift all of us, enable our work on the hardest of problems, empower us to invent and create, and ultimately save one billion lives. Join us: www.atomwise.com/careers
|
Open
|
Machine Learning, Artificial Intelligence, Drug Discovery, and Computer Aided Drug Design
|
Open
|
717 Market St.
|
San Francisco
|
California
|
US
|
94103
|
|
Atomwise
|
Health Care
|
Health Care Equipment & Services
|
private:atomwise
|
3357332
|
Apr 15th, 2024 12:00AM
|
Atomwise
|
19K
|
63.00
|
Open
|
|
Apr 15th, 2024 06:54AM
|
Apr 15th, 2024 07:15PM
|
Atomwise is a preclinical pharma company revolutionizing how drugs are discovered with AI. Atomwise has strengthened its drug discovery and development expertise by expanding its Board of Directors and creating a Scientific Advisory Board (SAB). These appointments signal a critical milestone for Atomwise as the company focuses on its own internal pipeline.
We invented the use of deep learning for structure-based drug discovery, today developing a pipeline of small-molecule drug candidates advancing into preclinical studies. Our AtomNet® technology has been used to unlock more undruggable targets than any other AI drug discovery platform. We are tackling over 600 unique disease targets with more than 250 partners around the world, including leading pharmaceutical, agrochemical, and emerging biotechnology companies. Atomwise has raised over $174 million from leading venture capital firms to advance our mission to make better medicines, faster.
We’re at a critical time in history where our need for new kinds of medicines is greater than any time in human memory. Fortunately, we can leverage advancing technology and scientific breakthroughs to accelerate discovery. New data, new algorithms, new compute platforms lift all of us, enable our work on the hardest of problems, empower us to invent and create, and ultimately save one billion lives. Join us: www.atomwise.com/careers
|
Open
|
Machine Learning, Artificial Intelligence, Drug Discovery, and Computer Aided Drug Design
|
Open
|
717 Market St.
|
San Francisco
|
California
|
US
|
94103
|
|
Atomwise
|
Health Care
|
Health Care Equipment & Services
|
private:atomwise
|
3357332
|
Apr 14th, 2024 12:00AM
|
Atomwise
|
19K
|
63.00
|
Open
|
|
Apr 14th, 2024 02:43AM
|
Apr 14th, 2024 02:43AM
|
Atomwise is a preclinical pharma company revolutionizing how drugs are discovered with AI. Atomwise has strengthened its drug discovery and development expertise by expanding its Board of Directors and creating a Scientific Advisory Board (SAB). These appointments signal a critical milestone for Atomwise as the company focuses on its own internal pipeline.
We invented the use of deep learning for structure-based drug discovery, today developing a pipeline of small-molecule drug candidates advancing into preclinical studies. Our AtomNet® technology has been used to unlock more undruggable targets than any other AI drug discovery platform. We are tackling over 600 unique disease targets with more than 250 partners around the world, including leading pharmaceutical, agrochemical, and emerging biotechnology companies. Atomwise has raised over $174 million from leading venture capital firms to advance our mission to make better medicines, faster.
We’re at a critical time in history where our need for new kinds of medicines is greater than any time in human memory. Fortunately, we can leverage advancing technology and scientific breakthroughs to accelerate discovery. New data, new algorithms, new compute platforms lift all of us, enable our work on the hardest of problems, empower us to invent and create, and ultimately save one billion lives. Join us: www.atomwise.com/careers
|
Open
|
Machine Learning, Artificial Intelligence, Drug Discovery, and Computer Aided Drug Design
|
Open
|
717 Market St.
|
San Francisco
|
California
|
US
|
94103
|
|
Atomwise
|
Health Care
|
Health Care Equipment & Services
|
private:atomwise
|
3357332
|
Apr 13th, 2024 12:00AM
|
Atomwise
|
19K
|
63.00
|
Open
|
|
Apr 13th, 2024 01:40AM
|
Apr 13th, 2024 01:58PM
|
Atomwise is a preclinical pharma company revolutionizing how drugs are discovered with AI. Atomwise has strengthened its drug discovery and development expertise by expanding its Board of Directors and creating a Scientific Advisory Board (SAB). These appointments signal a critical milestone for Atomwise as the company focuses on its own internal pipeline.
We invented the use of deep learning for structure-based drug discovery, today developing a pipeline of small-molecule drug candidates advancing into preclinical studies. Our AtomNet® technology has been used to unlock more undruggable targets than any other AI drug discovery platform. We are tackling over 600 unique disease targets with more than 250 partners around the world, including leading pharmaceutical, agrochemical, and emerging biotechnology companies. Atomwise has raised over $174 million from leading venture capital firms to advance our mission to make better medicines, faster.
We’re at a critical time in history where our need for new kinds of medicines is greater than any time in human memory. Fortunately, we can leverage advancing technology and scientific breakthroughs to accelerate discovery. New data, new algorithms, new compute platforms lift all of us, enable our work on the hardest of problems, empower us to invent and create, and ultimately save one billion lives. Join us: www.atomwise.com/careers
|
Open
|
Machine Learning, Artificial Intelligence, Drug Discovery, and Computer Aided Drug Design
|
Open
|
717 Market St.
|
San Francisco
|
California
|
US
|
94103
|
|
Atomwise
|
Health Care
|
Health Care Equipment & Services
|
private:atomwise
|
3357332
|
Apr 12th, 2024 12:00AM
|
Atomwise
|
19K
|
63.00
|
Open
|
|
Apr 12th, 2024 01:52AM
|
Apr 12th, 2024 11:01AM
|
Atomwise is a preclinical pharma company revolutionizing how drugs are discovered with AI. Atomwise has strengthened its drug discovery and development expertise by expanding its Board of Directors and creating a Scientific Advisory Board (SAB). These appointments signal a critical milestone for Atomwise as the company focuses on its own internal pipeline.
We invented the use of deep learning for structure-based drug discovery, today developing a pipeline of small-molecule drug candidates advancing into preclinical studies. Our AtomNet® technology has been used to unlock more undruggable targets than any other AI drug discovery platform. We are tackling over 600 unique disease targets with more than 250 partners around the world, including leading pharmaceutical, agrochemical, and emerging biotechnology companies. Atomwise has raised over $174 million from leading venture capital firms to advance our mission to make better medicines, faster.
We’re at a critical time in history where our need for new kinds of medicines is greater than any time in human memory. Fortunately, we can leverage advancing technology and scientific breakthroughs to accelerate discovery. New data, new algorithms, new compute platforms lift all of us, enable our work on the hardest of problems, empower us to invent and create, and ultimately save one billion lives. Join us: www.atomwise.com/careers
|
Open
|
Machine Learning, Artificial Intelligence, Drug Discovery, and Computer Aided Drug Design
|
Open
|
717 Market St.
|
San Francisco
|
California
|
US
|
94103
|
|
Atomwise
|
Health Care
|
Health Care Equipment & Services
|